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Background: There is an ongoing debate on the potential association between obesity and atopy. However, no
previous studies have investigated whether this relationship depends on sex and smoking status in Chinese adults.
Methods: In this hospital-based, case–control study, we recruited 1150 atopic cases aged 18 years or older and
1245 healthy control participants during April 2009 and December 2012 in Harbin, China. We conducted structured
questionnaire interviews, anthropometry measurements and serum allergen-specific immunoglobulin E (IgE) testing.
Univariate and multivariate logistic regression models were used to explore the relationship between obesity and
atopy risk stratified by sex and smoking status.
Results: There was an association between obesity and an increased risk of atopic sensitization after adjusting for
age, educational, family history, smoking and alcohol consumption (OR: 2.61, 3.25; 95% CI: 1.57-4.33,1.91-5.56 in
males and females, respectively). The association between BMI and allergic sensitization depended on smoking
status. In both genders, the association of obesity with atopic sensitization risk was stronger in non-smokers than in
current smokers. In males, ORs of atopic sensitization for obesity were 3.15 (95% CI, 1.46-6.68) for non-smokers and
2.22 (95% CI, 1.10-4.48) for current smokers. The corresponding ORs in females were 3.51 (95% CI, 1.98-6.24) and
2.22 (95% CI, 0.46-10.68) for non-smokers and current smokers, respectively. After excluding those subjects who with
pre-existing allergic conditions, the same relationship still remained.
Conclusions: Obesity is positively and significantly associated with the risk of atopy in both men and women as
well in both smokers and non-smokers in China. In addition, the relationship between obesity and atopic
sensitization is stronger in non-smokers than in current smokers.
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The prevalence of allergic diseases has increased in recent
years [1-3], especially in low and middle income countries
like China [4,5]. Atopy refers to a hereditary predisposition
of some individuals to develop immunoglobulin E anti-
bodies (IgE) to common allergens [6], commonly preced-
ing the development of allergic diseases [7] and usually* Correspondence: liumeina369@163.com
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unless otherwise stated.defined as having detectable allergen specific IgE either by
serum IgE tests, skin prick tests or other laboratory exami-
nations. Considering the rapid rise of allergic disorders,
understanding the associations of potential factors with
atopic sensitization has important clinical and public
health implications.
Obesity has been linked to the increase risk of atopic
sensitization in some epidemiological studies [8-12], while
other studies demonstrated that there is no association be-
tween obesity and atopic sensitization [13-17]. The reasons
for these contradictory findings might be due to differences. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sample sizes. For instance, in a study of Chinese men and
women, no association was found between body mass
index (BMI) and allergic sensitization, whereas percent
body fat (%BF) was found to be associated with a higher
rate of allergic sensitization in men but no associations be-
tween %BF and any sensitization in women [10]. In an-
other study, obesity was associated with a higher risk of
atopy, and this association was largely driven by food
sensitization [12]. Some studies have found association be-
tween obesity and allergic sensitization, while others have
not. Gender might also play an important role in the asso-
ciation between obesity and atopic sensitization. From a
biological view, sex hormone may contribute to the in-
creased risk of atopy [18]. Moreover, females have higher
amount of body fat than males [19], which might increase
the risk of atopic sensitization in females, but epidemio-
logical evidence is still inconsistent [9,10]. Therefore, it is
necessary to clarify the relationship between obesity and
atopic sensitization stratified by gender.
Cigarette smoking may reduce atopic sensitization,
and this association was confirmed in several cross-
sectional and longitudinal studies, even though some
bias cannot be ruled out such as healthy smoker bias
and self-selection bias [20-27]. Consistent with previous
studies, a 32-year well designed population-based cohort
study supported the hypothesis that the suppressive
effects on immune system of smoking protect against
atopy [27]. Therefore, the negative relationship between
smoking and the incidence of allergic sensitization could
partly explained by an immunosuppressive effect. Con-
sidering that adipose tissue can also be involved in in-
flammatory processes [28], there might be a complex
relation between body weight and smoking status, which
could affect the incidence of allergic sensitization.
On the one hand, due to the increased metabolic rate
[29-31] or restricting caloric absorption [32], body weight
in current smokers is generally less than that in never
smokers. This may reduce the risk of obese individ-
uals with increased atopic sensitization. On the other
hand, ex-smokers often gain weight after smoking cessa-
tion [33-36], which may cause a higher risk of atopic
sensitization. Therefore, the association between body
weight and atopic sensitization may be modified by
smoking status. However, as far as we know, no previous
studies have examined the relationship between obesity
and IgE-mediated allergen sensitization by smoking sta-
tus in Chinese adults.
In this hospital-based case control study, we aimed to
investigate the association between obesity and atopic
sensitization among Chinese adults. We are particularly
interested in exploring this association between obesity
and atopy stratified by gender and smoking status. Un-
derstanding whether the association between obesity andatopy depends on gender and smoking status is import-
ant for developing tailored intervention strategies.
Methods
Study participants
This is a hospital-based, case–control study conducted
at the Allergy Department of First Affiliated Hospital of
Harbin Medical University in Harbin, China. Written
informed consents were obtained from all subjects in-
volving in this study. This study was approved by the
Human Ethics Review Board, Harbin Medical University.
(Reference number is HMUIRB20120019).
From April 2009 to December 2012, all subjects who
visited the Department of Allergy in the First Affiliated
Hospital of Harbin Medical University underwent the
specific IgE testing regardless of their pre-existing condi-
tions. Those aged 18 years or older were eligible for this
study. Cases and controls were identified based on the
results of the specific IgE testing. We identified cases in-
cluding those who were newly diagnosed atopy based on
positive specific IgE testing to at least 1 of the 13 most
common local aeroallergens and food allergens. Those
cases who had been previously diagnosed with allergic
conditions were also confirmed positive in at least one
of the IgE tests. Potential controls included healthy
adults who visited the same department of the hospital
for a health check-up during the same period. Final eli-
gible controls were those who were negative in all spe-
cific IgE tests, and had not been previously diagnosed of
any allergic diseases (included allergic eczema, allergic
asthma, allergic rhinitis and food allergy). Among cases
and controls, athletes, those currently undergoing pro-
fessional anaerobic training, and pregnant or breastfeed-
ing women were excluded because their obesity status
could not be appropriately determined using body mass
index. Subjects who did not take serum allergen-specific
IgE testing, were not willing to complete the question-
naire interview or anthropometry measurements were
also excluded from the study. In addition, we excluded
those subjects who were ex-smokers due to small number
of ex-smokers(men, 25 cases and 44 controls; women, 13
cases and 16 controls) for estimating the association be-
tween obesity and atopic sensitization. Finally, our analysis
included the data from 2395 participants (1150 atopic sub-
jects and 1245 non-atopic subjects).
Questionnaire
A face-to-face interview was conducted by trained inter-
viewers. One page questionnaire included personal demo-
graphic factors (sex, age, educational level), family history
(parents, siblings, and children with related diseases includ-
ing allergic asthma, allergic rhinitis, allergic eczema and
food allergy), smoking status and alcohol consumption.
Age was calculated as the difference between the year of
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gorized into three groups: illiterate/elementary school,
junior/senior high school, and college, university or higher.
Current smokers were defined on the basis of the World
Health Organization criteria, as those who self-reported
smoking every day for at least 6 months [37]. Regular alco-
hol drinkers were defined as drinking more than twice per
week for at least one year.
BMI calculation and classification
According to a standard protocol [38], we measured
weight and height of all participants. Subjects were re-
quired to dress in normal indoor clothing and without
shoes, weighed to the nearest 0.1 kg using a calibrated
standard scale. Height was measured to the nearest 0.1 cm
using a stadiometer (Detecto-Scales; Brooklyn, NY). The
physician who conducted anthropometry did not know the
purpose of this study. BMI was calculated as weight (kg)/
[height (m)]2. All subjects were grouped into one of the fol-
lowing three groups, normal weight (BMI < 24), overweight
(BMI ≥ 24 and BMI < 28) and obesity (BMI ≥ 28) according
to the criteria established in 2003 by the Working Group
on Obesity in China [39].
Allergen-specific IgE testing and atopy
Serum samples were tested for allergen-specific IgE using
the AllergyScreen system (Mediwiss Analytic GmbH,
Germany). The choice of allergens was based on the epi-
demiology of atopic sensitization in China. The thirteen
most common allergens in the northeast of China were
assessed, including seven aeroallergens and six food aller-
gens. Aeroallergens include Dermatophagoides pteronyssi-
nus, common ragweed and mugwort, Hop, cat and dog
fur, mould mixture (Penicillium notatum, Cladosporium
herbarum, Aspergillus fumigatus, Alternaria alternate),
tree pollen mixture (Robur, Elm, London Plane, Willow,
Cottonwood) and German cockroach. Food allergens
include egg white/egg yolk, fish, crab, shrimp, milk and
beef. Atopy was defined as if the concentration of a least
one allergen-specific IgE was 0.35 kU/L or greater.
Statistical analysis
The baseline characteristics of cases and controls were
examined. Age was categorized into three groups: 18–
39,40-59, ≥60 years. The associations of categorical
variables with atopy were estimated using chi-squared
tests. To assess the associations of obesity with atopic
sensitization and to control for the potential confounding
factors, crude and adjusted odds ratio (OR) and their
95% confidence intervals (CI) were calculated using logis-
tic regressions. Separate analyses were conducted for dif-
ferent genders and smoking status. A two-sided p value
of less than 0.05 was taken to indicate statistical sig-
nificance for all estimates. The effect modifications ofgender and smoking status on a multiplicative scale were
assessed by including interaction terms between BMI and
gender or smoking status in logistic regression models. A
p value for the interaction term of less than 0.10 was con-
sidered evidence of interaction. Stratified models were
used to assess the associations between BMI and atopy
where evidence for interaction was found. The p values
for linear trends were calculated by entering the ordinal
variable of BMI as a continuous term in the regression
model. All analyses were performed using statistical SAS
9.1 (SAS Inc., Cary, NC, USA).
Results
In the present study, a total of 2395 participants were re-
cruited, including 361 men cases and 384 men controls,
789 women cases and 861 women controls. The numbers
and percentage of demographic characteristics, smoking
status of cases and controls by gender are shown in
Table 1. Both men and women cases were more likely to
have higher educational level than controls and to have
higher proportion of obesity than controls. In addition,
controls were more likely than cases to be older in men.
However, age difference was not seen in women. With re-
gard to family allergic disease history, smoking status and
regular alcohol drinking status, the differences between
atopic sensitization group and non-atopic sensitization
group were not statistically significant.
Table 2 shows the associations between BMI classifica-
tion and atopic sensitization in males and females. The
strength of the association between obesity and atopic
sensitization depended on sex with a significant sex-BMI
interaction term (peffect modification = 0.0414). Compared
to men with normal BMI, obese men had a notably in-
creased risk of atopic sensitization after adjusting for
age, educational, family history, smoking and alcohol
consumption (OR, 2.61; 95% CI, 1.57-4.33). This associ-
ation is stronger in women (OR, 3.25; 95% CI, 1.91-5.56),
after adjusting for the same set of confounding factors.
In order to exclude allergic induced obesity, such as
those with reduced physical activity or side reaction of
therapy related to allergic diseases, we excluded subjects
with previously diagnosed allergic diseases. The strength
of association between BMI and atopic sensitization
varied between men and women. Obesity was posi-
tively associated with atopic sensitization with OR = 2.76
(95% CI, 1.54-4.95) in men, 2.93 (95% CI, 1.59-5.40) in
women. Interestingly, overweight women had a lower risk
of atopic sensitization than women with normal BMI with
OR= 0.76 (95% CI, 0.60-0.96). Even after adjusting for
other confounding factors, this association still existed
(OR, 0.76; 95% CI, 0.59-0.97). However, when we excluded
those women with prior allergic diseases, this associ-
ation was no longer statistically significant at the 5% level
(OR, 0.76; 95% CI, 0.56-1.02).
Table 1 Characteristics of atopic sensitization cases and hospital health controls in men and women
Men Women
Case Control P value Case Control P value
N (%) N (%) N (%) N (%)
N 361 384 789 861
Age (years) 0.0286 0.0778
18-39 212 (58.73) 189 (49.22) 435 (55.13) 433 (50.29)
40-59 128 (35.46) 163 (42.45) 315 (39.92) 391 (45.41)
≥60 21 (5.82) 32 (8.33) 39 (4.94) 37 (4.30)
Educational level 0.0004 <0.0001
1st 88 (24.38) 60 (15.63) 176 (22.31) 105 (12.20)
2nd 129 (35.73) 188 (48.96) 313 (39.67) 492 (57.14)
3rd 144 (39.89) 136 (35.42) 300 (38.02) 264 (30.66)
Family allergic disease history 0.6750 0.6302
No 304 (84.21) 319 (83.07) 628 (79.59) 677 (78.63)
Yes 57 (15.79) 65 (16.93) 161 (20.41) 184 (21.37)
Smoking status 0.6383 0.8020
No 212 (58.73) 232 (60.42) 739 (93.66) 809 (93.96)
Current smoking 149 (41.27) 152 (39.58) 50 (6.34) 52 (6.04)
Regular alcohol drinkers 0.6501 0.8944
No 216 (59.83) 236 (61.46) 748 (94.80) 815 (94.66)
Yes 145 (40.17) 148 (38.54) 41 (5.20) 46 (5.34)
BMI 0.0016 <0.0001
Normal 178 (49.31) 224 (58.33) 582 (73.76) 629 (73.05)
Overweight 129 (35.73) 132 (34.38) 149 (18.88) 212 (24.62)
Obesity 54 (14.96) 28 (7.29) 58 (7.35) 20 (2.32)
Table 2 ORs and 95% CIs for atopy in relation to BMI category stratified by sex in all subjects and those without
allergic diseases
Men Women Effect
Case Control cOR (95% CI)a aOR (95% CI)b Case Control cOR (95% CI)a aOR (95% CI)b modification
N (%) N (%) N (%) N (%) P valuec
All participants
Normal 178 (49.31) 224 (58.33) 1.00 (ref) 1.00 (ref) 582 (73.76) 629 (73.05) 1.00 (ref) 1.00 (ref)
Overweight 129 (35.73) 132 (34.37) 1.23 (0.90-1.68) 1.29 (0.93-1.79) 149 (18.88) 212 (24.62) 0.76 (0.60-0.96) 0.76 (0.59-0.97) 0.0414
Obesity 54 (14.96) 28 (7.29) 2.43 (1.47-3.99) 2.61 (1.57-4.33) 58 (7.35) 20 (2.32) 3.13 (1.86-5.28) 3.25 (1.91-5.56)
P trend p = 0.0003 p = 0.0909
Without allergic
diseases
Normal 97 (47.55) 224 (58.33) 1.00 (ref) 1.00 (ref) 334 (73.89) 629 (73.05) 1.00 (ref) 1.00 (ref)
Overweight 76 (37.25) 132 (34.37) 1.33 (0.92-1.92) 1.41 (0.95-2.08) 89 (19.69) 212 (24.62) 0.79 (0.60-1.05) 0.76 (0.56-1.02) 0.0641
Obesity 31 (15.20) 28 (7.29) 2.56 (1.46-4.49) 2.76 (1.54-4.95) 29 (6.42) 20 (2.32) 2.73 (1.52-4.90) 2.93 (1.59-5.40)
P trend p = 0.0006 p = 0.3106
acOR, crude odds ratio; CI, confidence interval.
baOR, adjusted odds ratio; CI, confidence interval.
bAdjusted for age, educational levels, family allergic diseases history, smoking status and alcohol consumption.
cP value for effect modification by sex on the association of BMI category and atopic sensitization after adjustment.
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and females, we assessed the associations between BMI
category and atopy risk stratified by smoking status for
males and females separately. The association estimates
between BMI category and atopic sensitization risk
stratified by smoking status in each gender are shown in
Table 3. In men, the associations between BMI category
and atopic risk were statistically significant in non-smokers
(p trend = 0.0245) and current smokers (p trend = 0.0042)
while in women these trends were not statistically signifi-
cant. Smoking status modified the effect of BMI category
on atopy risk (peffect modification = 0.0349 and 0.0260 for men
and women, respectively). The OR of atopic sensitization
for obesity in men was slightly lower in current smokers
(2.22; 95% CI, 1.10-4.48) than that in never smokers (3.15;
95% CI, 1.49-6.68). Obesity was positively associated with
atopy (OR, 3.51; 95% CI, 1.98-6.24) in never smoking
women, but was not statistically significant in current
smokers (OR, 2.22; 95% CI, 0.46-10.68). Nevertheless, the
point estimates of OR indicated that obesity doubled the
odds of allergic sensitization regardless of their gender and
smoking status.
Table 4 presents the association estimates of BMI cat-
egory with atopic sensitization according to gender and
smoking status in those without existing allergic diseases.
Among current smoking men, BMI category was signifi-
cantly related with atopic sensitization (p trend = 0.0032).
Among never smoking men, obesity was positively associ-
ated with atopic sensitization (OR, 3.29; 95% CI, 1.37-7.95).
In never smoking women, obesity was significantly associ-
ated with an increased atopic risk (OR, 3.00; 95% CI, 1.56-
5.76). The effect modification by smoking status on the
association of BMI category and atopic sensitization wasTable 3 ORs and 95% CIs for atopy in relation to BMI stratifie
Never smokers
Case Control cOR (95% CI)a aOR (95% CI)b
N (%) N (%)
Men
Normal 102 (48.11) 118 (50.86) 1.00 (ref) 1.00 (ref) 7
Overweight 82 (38.68) 102 (43.97) 0.93 (0.63-1.38) 1.02 (0.67-1.55) 4
Obesity 28 (13.21) 12 (5.17) 2.70 (1.31-5.58) 3.15 (1.49-6.68) 2
P trend p = 0.0245
Women
Normal 549 (74.29) 587 (72.56) 1.00 (ref) 1.00 (ref) 3
Overweight 137 (18.54) 205 (25.34) 0.72 (0.56-0.91) 0.70 (0.54-0.91) 1
Obesity 53 (7.17) 17 (2.10) 3.33 (1.91-5.83) 3.51 (1.98-6.24) 5
P trend p = 0.2025
acOR, crude odds ratio; CI, confidence interval.
baOR, adjusted odds ratio; CI, confidence interval.
bAdjusted for age, educational levels, family allergic diseases history and alcohol co
cP value for effect modification by smoking status on the association of BMI categosignificant in men (peffect modification = 0.0081) but not so in
women (peffect modification = 0.0901).
For those subjects who were only allergic to aeroal-
lergens, the results of effect modification of smoking
status on the association between obesity and allergic
sensitization were similar with those of all subjects allergic
to all allergens and subjects without allergic diseases (data
not shown). In all subjects and those without allergic dis-
eases, the effect of BMI category on atopic sensitization
risk was still stronger in never smokers.
Discussion
In this hospital-based, case–control study, we demon-
strated that not only obesity was associated with atopic
sensitization in Chinese males and females, but also such
an association was modified by smoking status. We
found that the association between obesity and atopic
sensitization was stronger in never smokers than in
current smokers.
The findings on the association between obesity and
atopy in adults in the literature are inconsistent. An epi-
demiological study of adults in Canada and the US has
revealed a significant relationship between obesity and
atopy in both women and men [8]. In another birth co-
hort study, Hancox et al. reported that a raised BMI is
associated with allergic sensitization in women but not
in men [9]. In contrast, some studies reported contra-
dictory findings [13-17]. Those findings of other popula-
tions may not apply to Chinese because allergens, life
style and other related factors (such as smoking rate and
diet pattern) vary among different regions and cultures
[40]. Those variations might have contributed to the in-
consistent findings in different populations. In this study,d by sex and smoking status in all subjects
Current smokers Effect
Case Control cOR (95% CI)a aOR (95% CI)b Modification
N (%) N (%) P valuec
0.0349
6 (51.01) 106 (69.74) 1.00 (ref) 1.00 (ref)
7 (31.54) 30 (19.74) 2.19 (1.27-3.77) 2.15 (1.23-3.77)
6 (17.45) 16 (10.53) 2.27 (1.14-4.51) 2.22 (1.10-4.48)
p = 0.0042
0.0260
3 (66.00) 42 (80.77) 1.00 (ref) 1.00 (ref)
2 (24.00) 7 (13.46) 2.18 (0.77-6.16) 2.66 (0.83-8.51)
(10.00) 3 (5.77) 2.12 (0.47-9.53) 2.22 (0.46-10.68)
p = 0.1047
nsumption.
ry and atopic sensitization in men and women, respectively.
Table 4 ORs and 95% CIs for atopy in relation to BMI stratified by sex and smoking status in subject without allergic
diseases
Never smokers Current smokers Effect
Case Control cOR (95% CI)a aOR (95% CI)b Case Control cOR (95% CI)a aOR (95% CI)b Modification
N (%) N (%) N (%) N (%) P valuec
Men 0.0081
Normal 50 (47.62) 118 (50.86) 1.00 (ref) 1.00 (ref) 47 (47.47) 106 (69.74) 1.00 (ref) 1.00 (ref)
Overweight 41 (39.05) 102 (43.97) 0.95 (0.58-1.55) 0.98 (0.58-1.65) 35 (35.35) 30 (19.74) 2.63 (1.45-4.78) 2.50 (1.34-4.65)
Obesity 14 (13.33) 12 (5.17) 2.75 (1.19-6.37) 3.29 (1.37-7.95) 17 (17.17) 16 (10.53) 2.40 (1.12-5.15) 2.44 (1.10-5.38)
P trend p = 0.0671 p = 0.0032
Women 0.0910
Normal 313 (74.35) 587 (72.56) 1.00 (ref) 1.00 (ref) 21 (67.74) 42 (80.77) 1.00 (ref) 1.00 (ref)
Overweight 82 (19.48) 205 (25.34) 0.75 (0.56-1.00) 0.71 (0.52-0.96) 7 (22.58) 7 (13.46) 2.00 (0.62-6.45) 2.35 (0.62-8.95)
Obesity 26 (6.17) 17 (2.10) 2.87 (1.53-5.37) 3.00 (1.56-5.76) 3 (9.68) 3 (5.77) 2.00 (0.37-10.77) 3.60 (0.47-27.58)
P trend p = 0.5483 p = 0.1026
acOR, crude odds ratio; CI, confidence interval.
baOR, adjusted odds ratio; CI, confidence interval.
bAdjusted for age, educational levels, family allergic diseases history and alcohol consumption.
cP value for effect modification by smoking status on the association of BMI category and atopic sensitization in men and women without allergic
diseases, respectively.
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obesity and atopic sensitization in Chinese adults. Add-
itionally, our findings also support a possible sex differ-
ence in the relationship between obesity and atopic
sensitization which is consistent with a previous study
[9]. In our study, OR for obesity was greater in women
than in men, but even in men obesity increased risk of
allergic sensitization was more than 2 folds. However,
our findings are inconsistent with those of another study
conducted in China [10], in which no association be-
tween BMI category and allergic sensitization was found
but percent body fat was found to be associated with a
higher rate of allergic sensitization in men than women.
The different findings might be due to the differences in
the age of study subjects, the panel of allergens and the
original objectives between our study and theirs.
Although there are some limitations with the hospital
case–control study design, our finding on the relation-
ship between obesity and atopic sensitization being
modified by smoking status is intriguing. It suggests
the possibility that the association between obesity and
atopic sensitization is influenced by smoking status.
We demonstrated that the effects of obesity were
modified by smoking status in both genders. However,
obese adults had more than doubled the odds of having
atopic sensitization compared to those with normal BMI
regardless of their gender and smoking status. Such asso-
ciations were not substantially altered in the case of ex-
cluding subjects with previously existing allergic diseases.
It is not clear why smoking alters the association between
obesity and atopic sensitization. There are several pos-
sible interpretations. First, current smokers are likelyto have lower BMI than non-smokers due to the in-
creased metabolic rate [29-31] or restricting caloric ab-
sorption [32], which might reduce the effect of obesity on
atopic sensitization risk. Second, a common component
of cigarette smoke, such as nicotine, have been shown
to suppress various parameters of the immune system
[41,42]. The decreased risk of atopic sensitization in
smokers might result partially from the suppressive ef-
fects of the components of tobacco on the immune
system. Additionally, cigarette smoking could influence
atopic sensitization by an indirect mechanism. For ex-
ample, current smokers might be more likely to have
some respiratory tract symptoms, such as chronic cough.
It is possible that pathogenic bacteria could alter immune
function and affect the incidence of allergic sensitization.
Further studies are required to explore the true mecha-
nisms underlying the interaction between obesity and
smoking on atopic sensitization. Considering the harmful
effect of cigarette smoke, smoking is not encouraged in
preventing atopic disorders.
More interestingly, we found that overweight is associ-
ated with an increased risk of atopy in current smoking
men. Our results should be interpreted with caution. It is
worth noticing that BMI is not a perfect measure of excess
body fat [43], even though we excluded subjects for whom
BMI was not ideal to capture adiposity levels. The power
of BMI to distinguish between muscle and excess fat might
be limited, which could lead to misclassification of over-
weight and mild obesity [44]. Moreover, smoking is as-
sociated with a decrease in body weight, which might
contribute to the observed relationship between over-
weight and atopy in current smoking men and women.
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sample size of men and women cases and controls, which
enable us to look at the effect modification by sex and
smoking status on the association of obesity with atopic
sensitization. Moreover, obesity was defined according to
the current Chinese standard, which could better capture
the link between BMI and atopic sensitization in Chinese
population. In addition, we were able to assess that the
association between obesity and atopic sensitization ac-
cording to smoking status for the first time.
Our study also had several limitations. First, we did
not measure the waist circumference (WC) or the waist-
to-hip ratio (WHR). Those measurements are consid-
ered to have better correlated with tobacco smoking
than BMI [45]. Nevertheless, BMI has been traditionally
used as a surrogate measure of adiposity and is the most
frequently used diagnostic tool for obesity. Therefore,
our findings largely reflect the associations between
obesity and allergic sensitization in Chinese population.
Second, sample sizes for subgroup analyses for men and
women could decrease the power to detect associations.
Although we have a relatively large sample size, some
subgroup had small numbers of subjects and effect esti-
mates should be interpreted with caution as reflected in
the wide confidence intervals. Third, as an observational
case–control study, we could not establish a causal link
between smoking on the association between obesity
and atopy. In addition, selection bias in this study might
exist. Atopic patients who came to the allergy depart-
ment in this hospital were more likely to have a severe
symptom of atopy. Finally, we did not obtain data on
some important potential confounders, such as physical
activity, an important factor for body weight. Since our
study was conducted in a single hospital in Harbin,
China, the generalizability of our findings to Chinese in
other regions or to other populations remains to be fur-
ther assessed.
Conclusions
Obesity is significantly associated with the risk of atopic
sensitization in male and female adults in China. In
addition, smoking status modified the effect of BMI on
atopy risk. Although the association between BMI cat-
egory and atopic sensitization is less strong in current
smokers than in non-smokers, obesity increases the risk
of atopic sensitization for obesity by more than two folds
regardless of their gender and smoking status. Our find-
ings have important public implications for developing
strategies of preventing allergic sensitization.
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